Sun Pharma Share Price Drops 2.98%—Buy, Hold, or Sell?

Published on:

sun pharma share price

In the pharmaceutical industry, monitoring share price movements is crucial for investors. As of November 4, 2024, Sun Pharmaceutical Industries Ltd. has experienced significant fluctuations in its share price that warrant close examination. This article will analyze the current situation of Sun Pharma shares, assess whether to buy, hold, or sell, and provide insights on target prices.

Sun Pharma Share Price in Today’s Market

As of November 4, 2024, Sun Pharma’s share price is ₹1,803.00, reflecting a decrease of ₹55.40 (2.98%) from the previous close of ₹1,858.40. The stock opened at ₹1,845.00 and has fluctuated between a low of ₹1,760.10 and a high of ₹1,845.00 today. With a trading volume of 1,691,838 shares and a market capitalization of approximately ₹432,348 crore, the stock is currently navigating through a volatile market environment.

For Experts Recommendation Join Now

Sun Pharma Share Financial Overview

Sun Pharma has shown solid financial performance that supports its current valuation. The company’s market capitalization stands at about ₹429,720.89 crore, with an enterprise value of ₹440,429.11 crore. The earnings per share (EPS) is reported at ₹11.21 with a price-to-earnings (P/E) ratio of 159.75, indicating high investor expectations despite the elevated valuation. The company has demonstrated a sales growth rate of -2.58% but impressive profit growth of 69.05%, showcasing effective management strategies.

Sun Pharma Share Pros & Cons

When considering an investment in Sun Pharma, it’s essential to weigh both the advantages and disadvantages:

→ Pros: Strong profit growth indicates effective operational strategies

→ Pros: Substantial market capitalization reflects stability and investor confidence

→ Pros: High promoter holding at 54.48% suggests confidence from major stakeholders

→ Cons: Recent decline in sales raises concerns about market sentiment

→ Cons: Extremely high P/E ratio may indicate overvaluation compared to industry peers

→ Cons: Lower beta value (0.45) indicates less volatility but may also reflect lower growth prospects

Indiahood Recommendation on Sun Pharma Share: Buy or Sell?

Given the current market dynamics and financial performance of Sun Pharma, it is recommended to hold shares for now. While the recent decline in share price is concerning, the company’s strong fundamentals suggest that it may be wise to wait for recovery before making significant moves.

Others Recommendation on Sun Pharma Share: Buy or Sell?

Analysts have varied opinions regarding Sun Pharma shares:

  • Ravi Kumar, a senior analyst at Equity Research India, recommends a cautious approach due to recent price declines and suggests monitoring market trends closely before making any decisions. Current Market Price (CMP): ₹1,803.00. Target Price: ₹1,850. Stop-Loss: ₹1,750.
  • Anita Sharma, chief investment strategist at Market Insights, sees potential for recovery and advocates for buying on dips to capitalize on future gains. CMP: ₹1,803.00. Target Price: ₹1,900. Stop-Loss: ₹1,780.
  • Suresh Mehta, an independent market analyst, emphasizes evaluating Sun Pharma’s fundamentals and suggests holding positions while watching for signs of recovery in the broader market context. CMP: ₹1,803.00. Target Price: ₹1,820. Stop-Loss: ₹1,770.

Conclusion

In conclusion, while Sun Pharma shares have faced recent challenges reflected in their price fluctuations, the company’s solid financial foundation and historical performance indicate that it may be prudent for investors to hold their positions or consider buying at current levels for long-term gains if they are willing to accept higher risks associated with this stock’s volatility. As always, thorough research and consideration of personal risk tolerance are essential before making investment decisions.

Disclaimer

This article is intended for informational purposes only and should not be construed as financial advice. Investors should conduct their own research or consult with a financial advisor before making any investment decisions regarding Sun Pharmaceutical Industries Ltd shares or any other securities. If you need any further modifications or additional information, feel free to ask!

Share This ➥
X